Form 8-K - Current report:
SEC Accession No. 0001104659-22-033098
Filing Date
2022-03-14
Accepted
2022-03-14 07:30:22
Documents
14
Period of Report
2022-03-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm229163d1_8k.htm   iXBRL 8-K 33159
2 EXHIBIT 10.1 tm229163d1_ex10-1.htm EX-10.1 23872
3 EXHIBIT 99.1 tm229163d1_ex99-1.htm EX-99.1 6209
  Complete submission text file 0001104659-22-033098.txt   245258

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ntra-20220311.xsd EX-101.SCH 3027
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ntra-20220311_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ntra-20220311_pre.xml EX-101.PRE 22591
8 EXTRACTED XBRL INSTANCE DOCUMENT tm229163d1_8k_htm.xml XML 3605
Mailing Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753
Business Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 650-249-9090
Natera, Inc. (Filer) CIK: 0001604821 (see all company filings)

EIN.: 010894487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37478 | Film No.: 22735086
SIC: 8071 Services-Medical Laboratories